Targeted genome regulation and modification using transcription activator-like effectors

FEBS Journal

Volumn 281, Issue 20, 2014, Pages 4583-4597

  Scott, James N F ^a   Kupinski, Adam P ^a   Boyes, Joan ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Chromatin markers; CRISPR Cas9; Genome engineering; TALE proteins; Transcription regulation; Zinc finger nucleases

Indexed keywords

CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT ASSOCIATED PROTEIN 9; CRISPR ASSOCIATED PROTEIN; ENDONUCLEASE; FLUORESCENT DYE; FOK I ENDONUCLEASE; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER NUCLEASE; TRANSACTIVATOR PROTEIN;

CARBOXY TERMINAL SEQUENCE; CHROMATIN; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; DNA METHYLATION; DNA MODIFICATION; DNA SEQUENCE; DOUBLE STRANDED DNA BREAK; ENZYME MECHANISM; GENE DELETION; GENE INSERTION; GENETIC REGULATION; GENOME ANALYSIS; HIGH THROUGHPUT SEQUENCING; HUMAN; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN DNA BINDING; PROTEIN DOMAIN; REVIEW; RNA EDITING; TWO HYBRID SYSTEM; ANIMAL; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GENETICS; GENOME; METABOLISM;

XANTHOMONAS;

ANIMALS; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GENOME; HUMANS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 84915815117     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12973     Document Type: Review

References (86)

1. Boch J & Bonas U (2010) Xanthomonas AvrBs3 familytype III effectors: discovery and function. Annu Rev Phytopathol 48, 419-436.
2. Li L, Atef A, Piatek A, Ali Z, Piatek M, Aouida M, Sharakuu A, Mahjoub A, Wang G, Khan S et al. (2013) Characterization and DNA-binding specificities of Ralstonia TAL-like effectors. Mol P lant 6, 1318-1330.
3. De Lange O, Schreiber T, Schandry N, Radeck J, Braun KH, Koszinowski J, Heuer H, Strauß A & Lahaye T (2013) Breaking the DNA-binding code of Ralstonia solanace arum TAL effectors provides new possibilities to generate plant resistance genes against bacterial wilt disease. New Phytol 199, 773-786.
4. R omer P, Hahn S, Jordan T, Strauss T, Bonas U & Lah aye T (2007) Plant pathogen recognition mediated by promoter activation of the pepper Bs3 resistance gene. Science 318, 645-648.
5. Kay S, Hahn S, Marois E, Hause G & Bonas U (2007) A bacterial effector acts as a plant transcription factor and induces a cell size regulator. Science 318, 648-651.
6. Pennisi E (2012) The tale of the TALEs. Science 338, 1408-1411.
7. Bonas U, Stall RE & Staskawicz B (1989) Genetic and structural characterization of the avirulence gene avrBs3 from Xanthomonas campestris pv. vesicatoria. Mol Gen Genet 218, 127-136.
8. Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A & Bonas U (2009) Breaking the code of DNA binding specificity of TALtype III effectors. Science 326, 1509-1 512.
9. Moscou MJ & Bogdanove AJ (2009) A simple cipher governs DNA recognition by TAL effectors. Science 326, 1501.
10. Cong L,Zhou R,Kuo Y,Cunniff M,Zhang F, 2012, Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains, Nat Commun, 3, 968.
11. Miller JC, Tan S, Qiao G, Barlow KA, Wang J, Xia DF, Meng X, Paschon DE, Leung E, Hinkley SJ et al. (2010) A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 29, 143-148.
12. Streubel J, Bl ucher C, Landgraf A & Boch J (2012) TAL effector RVD specificities and efficiencies. Nat Biotechnol 30, 593-595.
13. Meckler JF, Bhakta MS, Kim M-S, Ovadia R, Habrian CH, Zykovich A, Yu A, Lockwood SH, Morbitzer R, Els aesser J et al. (2013) Quantitative analysis of TALEDNA interactions suggests polarity effects. Nucleic Acids Res 41, 4118-4128.
14. Christian ML, Demorest ZL, Starker CG, Osborn MJ, Nyquist MD, Zhang Y, Carlson DF, Bradley P, Bogdanove AJ & Voytas DF (2012) Targeting G with TAL effectors: a comparison of activities of TALE Ns constructed with NN and NK repeat variable di-residues. PLoS ONE 7, e45383.
15. Mak AN, Bradley P, Cernadas RA, Bogdanove AJ & Stoddard BL (2012) The crystal structure of TAL effector PthXo1 bound to its DNA target. Science 335, 716-719.
16. Deng D, Yan C, Pan X, Mahfouz M, Wang J, Zhu J-K, Shi Y & Yan N (2012) Structural basis for sequence-specific recognition of DN A by TAL effectors. Science 335, 720-723.
17. Sanjana NE, Cong L, Zhou Y, Cunniff MM, Feng G & Zhang F (2012) A transcription activator-like effector toolbox for genome engineering. Nat Protoc 7, 171-192.
18. Gao H, Wu X, Chai J & Han Z (2012) Crystal structure of a TALE protein reveals an extended N-terminal DNA binding region. Cell Res 22, 1716-1720.
19. Lamb BM, Mercer AC & Barbas CF (2013) Directed evolution of the TALE N-terminal domain for recognition of all 50 bases. Nucleic Acids Res 41, 9779-9785.
20. Tsuji S, Futaki S & Imanishi M (2013) Creating a TALE protein with unbiased 50-T binding. Biochem Biophys Res Commun 441, 262-265.
21. Guilinger JP, Pattanayak V, Reyon D, Tsai SQ, Sander JD, Joung JK & Liu DR (2014) Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity. Nat Methods 11, 429-435.
22. Cermak T, Doyle EL, Christian M, Wang L, Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ & Voytas DF (2011) Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39, e82.
23. Ding Q, Lee Y-K, Schaefer EA, Peters DT, Veres A, Kim K, Kuperwasser N, Motola DL, Meissner TB, Hendriks WT et al. (2013) A TALEN genome-editing system for generating human stem cell-based d isease models. Cell Stem Cell 12, 238-251.
24. Li L, Piatek MJ, Atef A, Piatek A, Wibowo A, Fang X, Sabir JSM, Zhu J-K & Mahfouz MM (2012) Rapid and highly efficient constructi on of TALE-based transcriptional regulators and nucleases for genome modification. Plant Mol Biol 78, 407-416.
25. Reyon D, Tsai SQ, Khayter C, Foden JA, Sander JD & Joung JK (2012) FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol 30, 460-465.
26. Schmid-Burgk JL, Xie Z, Frank S, Virreira Winter S, Mitschka S, Kolanus W, Murray A & Benenson Y ( 2012) Rapid hierarchical assembly of medium-size DNA cassettes. Nucleic Acids Res 40, e92.
27. Schmid-Burgk JL, Schmidt T, Kaiser V, Honing K & Hornung V (2013) A ligation-independent cl oning technique for high-throughput assembly of transcription activator-like effector genes. Nat Biotechnol 31, 76-81.
28. Zhang F, Cong L, Lodato S, Kosuri S, Church GM & Arlotta P (2011) Efficient construction of sequencespecific TAL effectors for modulating mammalian transcription. Nat Biotechnol 29, 149-153.
29. Kim Y, Kweon J, Kim A, Chon JK, Yoo JY, Kim HJ, Kim S, Lee C, Jeong E, Chung E et al. (2013) A library of TAL effector nucleases spanning the human genome. Nat Biotechnol 31, 251-258.
30. Szurek B, Rossier O, Hause G & Bonas U (2002) Type III-dependent translocation of the Xanthomonas AvrBs3 protein into the plant cell. Mol Microbiol 46, 13-23.
31. Doyle EL, Booher NJ, Standage DS, Voytas DF, Brendel VP, Vandyk JK & Bogdanove AJ (2012) TAL Effector-nucleotide targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction. Nucleic Acids R es 40, W117-W122.
32. Neff KL,Argue DP,Ma AC,Lee HB,Clark KJ,Ekker SC (2013), Mojo Hand, a TALEN design tool for genome editing applications, BMC Bioinformatics, 14, 1.
33. Heigwer F, Kerr G, Walther N, Glaeser K, Pelz O, Breinig M & Boutros M (2013) E-TALEN: a web tool to design TALENs for genome engineering. Nucleic Acids Res 41, e190.
34. Lin Y, Fine EJ, Zheng Z, Antico CJ, Voit RA, Porteus MH, Cradick TJ & Bao G (2014) SAPTA: a new design tool for improving TALE nuclease activity. Nucleic Acids Res 42, e47.
35. Joung JK & Sander JD (2012) TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 14, 49-55.
36. Hockemeyer D, Wang H, Kiani S, Lai CS, Gao Q, Cassady JP, Cost GJ, Zhang L, Santiago Y, Miller JC et al. (2011) Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 29, 731-734.
37. Sander JD, Cade L, Khayter C, Reyon D, Peterson RT, Joung JK & Yeh J-RJ (2011) Targeted gene disruption in somatic zebrafish cells using engineered TALENs. Nat Biotechnol 29, 697-698.
38. Bedell VM, Wang Y, Campbell JM, Poshusta TL, Starker CG, Krug RG II, Tan W, Penheiter SG, Ma AC, Leung AYH et al. (2012) In vivo genome editing using a high-efficiency TALEN system. Nature 491, 114-118.
39. Huang P, Xiao A, Zhou M, Zhu Z, Lin S & Zhang B (2011) Heritable gene targeting in zebrafish using customized TALENs. Nat Biotechnol 29, 699-700.
40. Kato T, Miyata K, So nobe M, Yamashita S, Tamano M, Miura K, Kanai Y, Miyamoto S, Sakuma T & Yamamoto T et al. (2013) Production of Sry knockout mouse using TALEN via oocyte injection. Sci Rep 3, 3136.
41. Tesson L, Usal C, M-enoret S, Leung E, Niles BJ, Remy S, Santiago Y, Vincent AI, Meng X, Zhang L et al. (2011) Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol 29, 695-696.
42. Zhang Y, Zhang F, Li X, Baller JA, Qi Y, Starker CG, Bogdanove AJ & Voytas DF (2013) Transcription activator-like effector nucleases enable efficient plant genome engineering. Plant Physiol 161, 20-27.
43. Li T, Liu B, Chen CY & Yang B (2014) TALEN utilization in rice genome modifications. Methods, pii: S1046-2023(14)00121-2. doi: 10.1016/j.ymeth.2014. 03.019. [Epub ahead of print]
44. Liu J, Li C, Yu Z, Huang P, Wu H, Wei C, Zhu N, Shen Y, Chen Y, Zhang B et al. (2012) Efficient and specific modifications of the Drosophila genome by means of an easy TALEN strategy. J Genet Genomics 39, 209-215.
45. Hall B, Limaye A & Kulkarni AB (2009) Overview: generation of gene knockout mice. Curr Protoc Cell Biol, Chapter 19, Unit 19.12 19.12.1-17.
46. Aida T, Imahashi R & Tanaka K (2014) Translating human genetics into mouse: the impact of ultra-rapid in vivo genome editing. Dev Growth Differ 56, 34-45.
47. Li C, Qi R, Si ngleterry R, Hyle J, Balch A, Li X, Sublett J, Berns H, Valentine M, Valentine V et al. (2014) Simultaneous gene editing by injection of mRNAs encoding transcription activator-like effector nucleases into mouse zygotes . Mol Cell Biol 34, 1649-1658.
48. Moehle EA, Moehle EA, Rock JM, Rock JM, Lee YL, Lee YL, Jouvenot Y, Jouvenot Y, DeKelver RC, Dekelver RC et al. (2007) Targeted gene a ddition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci USA 104, 3055-3060.
49. Matsubara Y, Chiba T, Kashimada K, Morio T, Takada S, Mizutani S & Asahara H (2014) Transcription activator-like effector nuclease-mediated transduction of exogenous gene into IL2RG locus. Sci Rep 4, 5043.
50. Mussolino C, Alzubi J, Fine EJ, Morbitzer R, Cradick TJ, Lahaye T, Bao G & Cathomen T (2014) TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity. Nucleic Acids Res 42, 6762-6773.
51. Doyon Y, Vo TD, Mendel MC, Greenberg SG, Wang J, Xia DF, Miller JC, Urnov FD, Gregory PD & Holmes MC (2011) Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Method s 8, 74-79.
52. Guo J, Gaj T & Barbas CF (2010) Directed evolution of an enhanced and highly efficient FokI cleavage domain for zinc finger nucleases. J Mol Biol 400, 96-107.
53. Miller JC,Holmes MC,Wang J,Guschin DY,Lee YL,Rupniewski I,Beausejour CM.Waite AJ,Wang NS,Kim KA,et al., 2007, An improved zinc-finger nuclease architecture for highly specific genome edi ting, Nat Biotechnol, 25, 778-785.
54. Beurdeley M, Bietz F, Li J, Thomas S, Stoddard T, Juillerat A, Zhang F, Voytas DF, Duchateau P & Silva GH (2013) Compact designer TALE Ns for efficient genome engineering. Nat Commun 4, 1762.
55. Sadowski I, Ma J, Triezenberg S & Ptashne M (1988) GAL4-VP16 is an unusually potent transcriptional activator. Nature 335, 563-564.
56. Li Y, Moore R, Guinn M & Bleris L (2012) Transcription activator-like effector hybrids for conditional control and rewiring of chromosomal transgene expression. Sci Rep 2, 897.
57. Ayer DE, Laherty CD, Lawrence QA, Armstrong AP & Eisenman RN (1996) Mad proteins contain a dominant transcription repression domain. Mol Cell Biol 16, 5772-5781.
58. Margolin JF, F riedman JR, Meyer WK, Vissing H, Thiesen HJ & Rauscher FJ (1994) Kr uppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci USA 91, 4509-4513.
59. Uhde-Sto ne C, Cheung E & Lu B (2014) TALE activators regulate gene expression in a position-and strand-dependent manner in mammalian cells. Biochem Biophys Res Commun 443, 1189-1194.
60. Chen J, Zhang W, Lin J, Wang F, Wu M, Chen C, Zheng Y, Peng X, Li J & Yuan Z (2014) An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases. Mol Ther 22 , 303-311.
61. Miyanari Y, Ziegler-Birling C & Torres-Padilla M-E (2013) Live visualization of chromatin dynamics with fluorescent TALEs. Nat Struct Mol Biol 20, 1321-1324.
62. Ma H, Reyes-Gutierrez P & Pederson T (2013) Visualization of repetitive DNA sequences in human chromosomes with transcription activator-like effectors. Proc Natl Acad Sci USA 110, 21048-21053.
63. Maeder ML, Linder SJ, Reyon D, Angstman JF, Fu Y, Sander JD & Joung JK (2013) Robust, synergistic regulation of human gene expression using TALE activators. Nat Methods 10, 243-245.
64. Perez-Pinera P, Ousterout DG, Brunger JM, Farin AM, Glass KA, Guilak F, Crawford GE, Hartemink AJ & Gersbach CA (2013) Synergistic and tunable human gene activation by combinations of synthetic transcription fa ctors. Nat Methods 10, 239-242.
65. Scott JNF, Kupinski AP, Kirkham CM, Tuma R & Boyes J (2014) TALE proteins bind to both active and inactive chromatin. Biochem J 158, 153-158.
66. Deng D, Yin P, Yan C, Pan X, Gong X, Qi S, Xie T, Mahfouz M, Zhu J-K, Yan N et al. (2012) Recognition of methylated DNA by TAL effectors. Cell Res 22, 1502-1504.
67. Valton J, Dupuy A, Daboussi F, Thomas S, Mar-echal A, Macmaster R, Melliand K, Juillerat A & Duchateau P (2012) Overcoming transcription activator-like effector (TALE) DNA binding domain sensit ivity to cytosine methylation. J Biol Chem 287, 38427-38432.
68. Bultmann S, Morbitzer R, Schmidt CS, Thanisch K, Spada F, Elsaesser J, Lahaye T & Leonhardt H (2012) Targeted trans criptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acids Res 40, 5368-5377.
69. Maeder ML, Angstman JF, Richardson ME, Linder SJ, Cascio VM, Tsai SQ, Ho QH, Sander JD, Reyon D, Bernstein BE et al. (2013) Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat Biotechnol 31, 1137-1142.
70. Bibikova M, Golic M, Golic KG & Carroll D (2002) Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. Genetics 161, 1169-1175.
71. Bibikova M, Beumer K, Trautman JK & Carroll D (2003) Enhancing gene targeting with designed zinc finger nucleases. Science 300, 764.
72. Urnov FD, Rebar EJ, Holmes M C, Zhang HS & Gregory PD (2010) Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11, 636-646.
73. Pavletich NP & Pabo CO (1991) Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science 252, 809-817.
74. Carroll D (2011), Genome engineering with zinc-finger nucleases, Genetics, 188, 773-782.
75. Gommans WM, Haisma HJ & Rots MG (2005) Engineering zinc finger protein transcription factors: the therapeutic relevance of switching endogenous gene expression on or off at command. J Mol Biol 354, 507-519.
76. DeFrancesco L (2011) Move over ZFNs. Nat Biotechnol 29, 681-684.
77. Tebas P, Stein D, Tang WW, Frank I, Wang SQ, Lee G, Spratt SK, Surosky RT, Giedlin MA, Nichol G et al. (2014) Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 370, 901-910.
78. Scott CT (2005) The zinc finger nuclease monopoly. Nat Biotechnol 23, 915-918.
79. Mahfouz MM, Li L, Shamimuzzaman M, Wibowo A, Fang X & Zhu J-K (2011) De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creat es double-strand breaks. Proc Natl Acad Sci USA 108, 2623-2628.
80. Moore FE, Reyon D, Sander JD, Martinez SA, Blackburn JS, Khayter C, Ramirez CL, Joung JK & Langenau DM (2012) Improved somatic mutagenesis in zebrafish using transcription activator-like effector nucleases (TALENs). PLoS One 7, e37877.
81. Mali P, Esvelt KM & Church GM (2013) Cas9 as a versatile tool for engineering biology. Nat Methods 10, 957-963.
82. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA & Zhang F (2013) Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8, 2281-2308.
83. Xu T, Li Y, Van Nostrand JD, He Z & Zhou J (2014) Cas9-based tools for targeted genome editing and transcriptional control. Appl Environ Microbiol 80, 1544-1552.
84. Yang H, Wang H, Shivalila CS, Cheng AW, Shi L & Jaenisch R (2013) One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154, 13 70-1379.
85. Niu Y, Shen B, Cui Y, Chen Y, Wang J, Wang L, Kang Y, Zhao X, Si W, Li W et al. (2014) Generation of gene-modified cynomolgus monkey via Cas9/RNAmediated gene targeting in one- cell embryos. Cell 156, 836-843.
86. Chen B, Gilbert LA, Cimini BA, Schnitzbauer J, Zhang W, Li G-W, Park J, Blackburn EH, Weissman JS, Qi LS et al. (2013) Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155, 1479-1491.